Skip to main content
. 2013 Oct 15;6(11):2535–2541.

Table 1.

Correlation between the clinicopathological features and RhoGDI expression

Characteristics RhoGDI expression

Negative (%) Positive (%) P value
Group
    Non-tumor 44 (41.5) 62 (58.5) 0.123
    Tumor 40 (31.7) 86 (68.3)
Gender
    Male 36 (32.1) 76 (67.9) 0.787
    Female 4 (28.6) 10 (71.4)
Age
    <50 29 (41.4) 41 (58.6) 0.009*
    ≥50 11 (19.6) 45 (80.4)
Tumor size (cm in diameter)
    ≤5 14 (32.6) 29 (67.4) 0.888
    >5 26 (31.3) 57 (68.7)
Tumor differentiation
    Low 5 (29.4) 12 (70.6) 0.888
    Middle 16 (34.0) 31 (66.0)
    High 19 (30.6) 43 (69.4)
Liver cirrhosis
    No 15 (26.8) 41 (73.2) 0.285
    Yes 25 (35.7) 45 (64.3)
HBsAg status
    Negative 6 (37.5) 10 (62.5) 0.597
    Positive 34 (30.9) 76 (69.1)
Serum AFP
    Negative 10 (29.4) 24 (70.6) 0.732
    Positive 30 (32.6) 62 (67.4)
Postsurgical recurrence
    Negative 52 (66.7) 26 (33.3) 0.634
    Positive 30 (62.5) 18 (37.5)
Postsurgical metastasis
    No 32 (31.1) 71 (68.9) 0.729
    Yes 8 (34.8) 15 (65.2)
*

Statistically significant (P<0.05).